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The issue of genetically engineered (GE) crops has been a 
contentious one since shortly after the initial development of 
recombinant DNA manipulation techniques in the 1970s. It is a 
discussion which has played out frequently in the popular press, 
occasionally in sensational fashion, and left some people looking 
expectantly for great advances to eliminate world hunger, others 
apprehensive about consuming any GE food crops or feeding an-
imals GE crops and others worried about damage to the environ-
ment by release of a GE species. Adding to this discussion is a new 
report from the US National Academies of Sciences, Engineering, 
and Medicine, titled “Genetically Engineered Crops: Experiences 
and Prospects” released on May 17, 2016† [1,2].
Populations and governments around the world have re-
sponded to the perceived opportunities and threats of GE crops 
in decidedly different ways.  The report highlights some of these 
global differences with respect to the adoption or rejection of 
GE crops and the regulatory systems in place to deal with crops 
with novel traits. It looks back at the relatively short history of GE 
crops and considers what might be expected in the future. Most 
importantly, it looked at a very large body of published informa-
tion to search for evidence of adverse health effects of GE crops 
for humans or animals and concluded that none had been found. 
Neither did the committee find any cause and effect between GE 
crops and environmental problems. Since the first GE crops were 
commercialized in 1995, this amounts to a 20-year time horizon 
and, of course, does not preclude longer term effects, but, at least 
so far, there are no adverse effects apparent.
The academies’ committee distinguishes crops resulting from 
recombinant DNA technology as “genetically engineered.” Many 
others, especially in Europe, refer to these as “genetically mod-
ified organisms (GMO).” Indeed, even in the US, where a large 
quantity of GE/genetically modified (GM) crops are grown and 
consumed, a popular voluntary label of food goods is “no GMOs.” 
The rationale for the GE label for crops produced via recombinant 
DNA technology is that the DNA of crops has been modified by 
humans for millennia through selecting and propagating varieties 
with the most advantageous traits (that is what would be classi-
fied as conventional agriculture). Indeed, the committee points 
out that, with advances in conventional breeding, it is becoming 
unsupportable to distinguish novel crops by whether they were 
produced conventionally or by genetic engineering.
The National Academies’ first report on DNA technology was 
issued in 1974 by the Committee on Recombinant DNA Molecules 
and noted the potential hazards of the technology. By the 1980s, 
the technology had progressed to work in plants and the Acad-
emies began to advise government regulatory agencies and the 
public to pay more attention on genetic engineering in agricul-
ture. Prior to the subject report, the Academies produced 10 con-
sensus studies on GE in agriculture from 1985 to 2010 (See Ref. [1], 
Table1-1, p.19). Over that period, even as GE in agriculture has ad-
vanced, the controversy in many quarters has not abated. Indeed, 
in the preparation of the latest report, the committee heard pre-
sentations from 80 interested persons/organizations, received 
and considered more than 700 written comments from the public 
ranging from supportive to expressions of grave concern (See Ref. 
[1], Appendix F, p.370).
Starting from about 1995, global planting of GE crops grew to 
about 1.8 × 1012 m2 in 2015, accounting for 12% of global cropland. 
The US accounted for 7 × 1011 m2; Brazil, Argentina, India, and 
Canada collectively accounted for 9 × 1011 m2; the remainder was 
spread among 23 countries. Although a variety of GE plant species 
have been approved for public release, only three (maize, soy-
beans, and cotton) have been commercialized to any large extent, 
so these crops account for a large portion of the global fraction 
of GE crops. The global area for GE maize reached 5.37 × 1011 m2 
in 2015, about one-third of the total maize planted. GE soybean 
varieties were grown on 9.2 × 1011 m2 worldwide, 80% of the to-
tal 1.18 × 1012 m2 of cultivated soybean in 2015. Roughly half of 
US cropland was planted with GE maize, soybean, and cotton in 
2014.
A considerable number of crops with a variety of traits have 
been approved by regulators in the US (See Ref. [1], Table3-1, p.48), 
but the most common genetically engineered traits commercially 
available in the US and worldwide are pest resistance and herbi-
cide resistance, sometimes in combination. A major example of 
induced pest resistance occurs by the incorporation of Bacillus 
thuringiensis (Bt) genes in the plant to produce proteins called Bt 
toxins which are fatal to insects that eat the plant. This is com-
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monly used in maize. Herbicide resistance has been developed for 
a variety of herbicide-plant combinations, but the most common 
example is soybean resistant to glyphosate, known commercially 
as Roundup™. Yields (closer to “potential” yields, i.e., those the-
oretically achievable) are “preserved” in Bt pest resistant crops, 
although the results are variable and the increases are modest in 
comparison to non-Bt varieties. In combination with decreased 
use of pesticides, use of Bt crops usually yields favorable econom-
ic outcomes for the farmer. The results for herbicide resistant 
crops are also variable, but yield preservation is evident when 
weed control is improved because of the specific herbicide that is 
used with the crop. 
The report notes that introducing GE traits in crops to address 
a problem is not a case of “fix it and forget it.” There is a constant 
evolutionary race in play. Advances due to the introduction of GE 
crops can be at risk if appropriate agriculture management proce-
dures are not in place to discourage the development of plant pests 
resistant to Bt toxins and weeds resistant to the herbicide of choice. 
Acute health effects are usually readily detected and have not 
been observed with respect to GE crops. No apparent health ef-
fects have been realized in longer term studies either, as noted 
above. The committee also reported interesting broad-brush ob-
servations regarding cancer rates  (See Ref. [1], p.137).  A compari-
son of incidence rates for a variety of cancers for men and women 
in the US from 1975 to 2011 showed no evidence of an increased 
rate after 1996 when GE maize and soybean were introduced. 
Also, since GE/GM crops and foods from them are still generally 
unavailable in the United Kingdom, and assuming the absence 
of other confounding factors, cancer rates in the UK represent a 
control group for cancer rates in the US with the genetically engi-
neered crops as a variable. After comparing the data for a variety 
of cancers, no indications of negative effects due to the consump-
tion of GE foods in the US are found to be evident.    
As GE crops have been approved and commercialized over the 
past two decades, recombinant DNA techniques have been ad-
vanced and offer the opportunity to introduce genetic changes in 
a more controlled and targeted fashion, for example, the clustered 
regularly interspaced short palindromic repeats (CRISPR)/Cas9 
technique (See Ref. [1], p.244) can be used for precision genome 
editing. With the availability of such techniques and the unique 
alterations, there can be a challenge for regulators to establish 
that a GE crop does not represent a potential hazard. To date, 
differences in the composition of GE crops which have been de-
tected with current technologies are small compared to the vari-
ations which occur naturally in non-GE crops. More sophisticated 
techniques, such as using metabolomics to examine metabolites, 
will be useful in the future to characterize new GE crops. It also 
remains unclear whether newly emerging GE approaches will 
permit higher potential yields by improving photosynthesis and 
nutrient use. Until now, commercialized GE crops preserve yield, 
but do not have greater potential yield than their non-GE coun-
terparts. 
Even with the emergence of new recombinant DNA tech-
niques, conventional breeding techniques, such as mutagenesis by 
chemical or irradiation treatment in combination with new tools 
for deciphering DNA sequences, can be used to select plants with 
novel traits that are substantially equivalent to those produced 
by recombinant DNA techniques. In some regulatory systems, the 
former product would not be regulated, while the latter would 
because of the way it is produced. In others, the product would 
be regulated if it has novel traits, irrespective of the production 
path. The committee favors a product based regulatory approach, 
where a decision to regulate would be based on whether a 
product has novel traits. 
The European Union (EU) and Brazil specifically regulate 
based on process, that is, crops produced by genetic engineering. 
Canada regulates the product, irrespective of method produced. 
The US uses a product based approach, but the elements of how 
the product was developed do enter. There is also interplay of 
science based risk assessment and political assessment in the 
various approaches.  In the US and Canada, decisions are based 
on risk assessments by technical bodies. In the EU and Brazil, a 
risk assessment body hands-off to a political body. In Brazil, GE 
crops have been approved through the political process and Brazil 
has become the second largest producer of GE crops. The EU 
political body requires majority approval of the member states 
and adopts a precautionary approach. Irrespective of a favorable 
risk assessment, the member states had not reached a majority 
opinion on any case up to December 2015, accounting for the 
extremely limited cultivation of GE crops in Europe. Recently, 
the EU adopted an opt-out clause, where a country can prohibit 
cultivation, even if there is a majority vote for approval. The 
intent is to allow other EU countries to cultivate the approved GE 
crop if they so choose.  
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Fig. 1. Soybean (Glycine max).  As a key source of vegetable oil in the United 
States, soybeans were domesticated in China as far back as the 11th century B.C., 
and are currently the leading provider of protein and oil around the globe. Photo 
by Scott Bauer, available from: http://www.ars.usda.gov/is/graphics/photos/oct08/
k8324-3.htm.
